Skip to main content

Table 2 Multivariable-adjusted associations of α diversity measures with insulin resistance, diabetes duration, and stages of diabetes

From: Gut microbiome and stages of diabetes in middle-aged adults: CARDIA microbiome study

 

HOMA-IR

Diabetes duration

Stages of diabetes (reference: normal, n = 417)

Pre-diabetes

Diabetes without treatment

Diabetes with treatment

(n = 604)

(n = 605)

(n = 101)

(n = 31)

(n = 56)

β

95% CI

β

95% CI

β

95% CI

β

95% CI

β

95% CI

Shannon index

          

Model 1

 − 0.02

 − 0.05, 0.01

 − 0.02*

 − 0.05, − 0.003

 − 0.18

 − 0.40, 0.04

 − 0.18

 − 0.54, 0.19

 − 0.28*

 − 0.56, − 0.003

Model 2

 − 0.02

 − 0.05, 0.02

 − 0.03*

 − 0.05, − 0.004

 − 0.18

 − 0.40, 0.05

 − 0.16

 − 0.52, 0.21

 − 0.28

 − 0.56, 0.01

Model 3

0.003

 − 0.04, 0.04

 − 0.02*

 − 0.05, − 0.0004

 − 0.13

 − 0.35, 0.10

 − 0.04

 − 0.42, 0.33

 − 0.23

 − 0.52, 0.07

Model 4

 − 0.003

 − 0.05, 0.04

 − 0.03*

 − 0.05, − 0.005

 − 0.15

 − 0.37, 0.08

 − 0.06

 − 0.44, 0.31

 − 0.30*

 − 0.60, − 0.01

Richness

          

Model 1

 − 0.04*

 − 0.08, − 0.01

 − 0.04*

 − 0.06, − 0.02

 − 0.26*

 − 0.48, − 0.05

 − 0.43*

 − 0.79, − 0.07

 − 0.51*

 − 0.78, − 0.23

Model 2

 − 0.04*

 − 0.08, − 0.01

 − 0.04*

 − 0.07, − 0.02

 − 0.28*

 − 0.50, − 0.07

 − 0.42*

 − 0.78, − 0.06

 − 0.53*

 − 0.82, − 0.25

Model 3

 − 0.004

 − 0.05, 0.04

 − 0.04*

 − 0.06, − 0.02

 − 0.21

 − 0.43, 0.01

 − 0.26

 − 0.62, 0.11

 − 0.44*

 − 0.72, − 0.15

Model 4

 − 0.01

 − 0.05, 0.03

 − 0.04*

 − 0.06, − 0.02

 − 0.22

 − 0.44, 0.004

 − 0.27

 − 0.63, 0.10

 − 0.50*

 − 0.79, − 0.20

  1. Data source: The Coronary Artery Risk Development in Young Adults (CARDIA), 1985–2016
  2. HOMA-IR and diabetes duration were treated as continuous variables
  3. Model 1adjusted for sequencing run. Model 2 additionally adjusted for age, sex, race, field center, and education. Model 3 additionally adjusted for physical activity, smoking status, alcohol use, and diet quality score. In Model 4, medication use, such as proton pump inhibitor and lipid-lowering, was added
  4. HOMA-IR, Homeostatic Model Assessment for Insulin Resistance
  5. *Significance based on p-value < 0.05